Your browser doesn't support javascript.
loading
How Internet Websites Portray Herbal Vitality Products Containing Eurycoma longifolia Jack: An Evaluation of the Quality and Risks of Online Information.
Wahab, Mohd Shahezwan Abd; Abd Hamid, Nurfarah Nadiah; Yassen, Ali Omar; Naim, Mohd Javed; Ahamad, Javed; Zulkifli, Nur Wahida; Ismail, Farhana Fakhira; Zulkifli, Muhammad Harith; Goh, Khang Wen; Ming, Long Chiau.
Afiliação
  • Wahab MSA; Faculty of Pharmacy, Universiti Teknologi MARA (UiTM) Cawangan Selangor, Kampus Puncak Alam, Puncak Alam 42300, Malaysia.
  • Abd Hamid NN; Non-Destructive Biomedical and Pharmaceutical Research Centre, Smart Manufacturing Research Institute, Universiti Teknologi MARA (UiTM) Cawangan Selangor, Kampus Puncak Alam, Puncak Alam 42300, Malaysia.
  • Yassen AO; Faculty of Pharmacy, Universiti Teknologi MARA (UiTM) Cawangan Selangor, Kampus Puncak Alam, Puncak Alam 42300, Malaysia.
  • Naim MJ; Department of Clinical Pharmacy and Pharmacy Management, Tishk International University, Erbil 44001, Iraq.
  • Ahamad J; Department of Pharmaceutical Chemistry, Tishk International University, Erbil 44001, Iraq.
  • Zulkifli NW; Department of Pharmacognosy, Tishk International University, Erbil 44001, Iraq.
  • Ismail FF; Faculty of Pharmacy, Universiti Teknologi MARA (UiTM) Cawangan Selangor, Kampus Puncak Alam, Puncak Alam 42300, Malaysia.
  • Zulkifli MH; Faculty of Pharmacy, Universiti Teknologi MARA (UiTM) Cawangan Selangor, Kampus Puncak Alam, Puncak Alam 42300, Malaysia.
  • Goh KW; Faculty of Pharmacy, Universiti Teknologi MARA (UiTM) Cawangan Selangor, Kampus Puncak Alam, Puncak Alam 42300, Malaysia.
  • Ming LC; Faculty of Data Science and Information Technology, INTI International University, Nilai 71800, Malaysia.
Article em En | MEDLINE | ID: mdl-36231154
ABSTRACT

BACKGROUND:

Tongkat Ali (TA) or Eurycoma longifolia is a herbal medicine (HM) plant traditionally used to treat sexual dysfunction and enhance libido in men. Websites containing information about HM are abundant. However, studies have shown that in general the quality of websites containing information on HM is low. The present study aims to assess the quality and risks of websites containing information about TA supplements and to identify the health claims for TA.

METHODOLOGY:

A cross-sectional study to evaluate the quality and risks of websites discussing TA supplements was conducted. Online marketing websites, research articles, news articles, personal opinions, and those restricted by password were excluded. The quality and risks of websites were assessed using a modified DISCERN tool and a set of risk assessment criteria, respectively. The health claims for TA were identified and analyzed using content analysis.

RESULTS:

Overall, 321 websites met the inclusion criteria and were further evaluated. The overall rating of the quality of the websites was low, with a mean score ± standard deviation of 1.07 ± 0.51. Most websites lacked information that there may be more than one possible treatment choice and did not discuss areas of uncertainty. However, 67.9% (218/321) of the websites received a risk score of zero. A minority of websites (5/321, 1.6%) discouraged the use of conventional medicines. The most common health claims for TA included in the websites related to the enhancement of testosterone level (121/321, 37.7%), treatment of malaria (112/321, 34.9%), and improvement in libido (108/321, 33.6%).

CONCLUSIONS:

Websites containing information about TA supplements generally have a low-quality rating based on a modified DISCERN tool despite having a low-risk score. Government agencies and healthcare professionals (HCPs) must be more proactive in the critique and dissemination of information relating to HM, and in ensuring the safe use of HM among the public and patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Eurycoma Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Eurycoma Idioma: En Ano de publicação: 2022 Tipo de documento: Article